Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Tumor immunology Cytokines Interferons

Betulinic acid, TGR5 agonist (ab120654)

Price and availability

127 315 ₸

Availability

Order now and get it on Thursday February 25, 2021

Betulinic acid, TGR5 agonist (ab120654)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Anticancer agent. TGR5 agonist.
  • CAS Number: 472-15-1
  • Soluble in DMSO to 50 mM (with warming)
  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Human Interferon Gamma ELISPOT Kit (ab62899)
Product image
Anti-Interferon alpha/beta receptor 1 antibody (ab97701)
Product image
Rat IFN gamma ELISA Kit (ab113349)
Product image
Anti-IRF2BP1 antibody [OTI3A6] (ab236392)

Overview

  • Product name

    Betulinic acid, TGR5 agonist
  • Description

    Anticancer agent. TGR5 agonist.
  • Biological description

    Triterpenoid with various biological activities. Apoptosis inducer, with anticancer properties. Also shows anti-HIV, antimalarial and anti-inflammatory activity. TGR5 agonist (EC50 = 1.04 μM).

  • CAS Number

    472-15-1
  • Chemical structure

    Chemical Structure

Images

  • Functional Studies - Betulinic acid, TGR5 agonist (ab120654)
    Functional Studies - Betulinic acid, TGR5 agonist (ab120654)

    ab32557 staining p38 (phospho T180 + Y182) in MALME-3M cells treated with betulinic acid (ab120654), by ICC/IF. Increase in expression of p38 (phospho T180 + Y182) correlates with increased concentration of betulinic acid, as described in literature.
    The cells were incubated at 37°C for 30 minutes in media containing different concentrations of ab120654 (betulinic acid ) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab32557 (1/200 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-CD163 antibody [BLR087G] (ab265592)

  •  
  • Product image

    Anti-FSTL3 antibody (ab232761)

  •  
  • Product image

    Anti-PODXL antibody - C-terminal (ab203079)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.